期刊文献+

导管消融与室率控制治疗持续性房颤合并心力衰竭疗效比较的系统评价与Meta分析 被引量:1

Comparison between the efficacy of catheter ablation and ventricular rate control in treating persistent atrial fibrillation complicating heart failure:systematic evaluation and Meta analysis
下载PDF
导出
摘要 目的系统评价导管消融治疗持续性心房颤动合并心力衰竭的疗效。方法系统检索PubMed、Cochrane图书馆、Embase、ClinicalTrials. gov、中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBM)以及万方数据库,筛选并纳入采用导管消融与室率控制治疗持续性心房颤动合并心力衰竭疗效比较的试验,应用Revman 5. 3软件进行Meta分析。结果共入选5项研究,累计有423例患者,其中214例接受导管消融治疗。Meta分析结果显示,导管消融术后左心室射血分数(left ventricular ejection fraction,LVEF)显著升高,MD为5. 21%(95%CI:1. 69~8. 73,P=0. 004),但研究间存在显著异质性(I^2=80%,P=0. 000 6)。经调整纳入测量指标,行敏感性分析排除异质性来源之后,重新纳入软件进行Meta分析,文献间未发现异质性(I^2=0%,P=0. 49),此时LVEF的MD变为7. 31%(95%CI:5. 18~9. 45,P <0. 000 01)。同时,对导管消融治疗前后明尼苏达心功能不全生命质量量表、6 min步行距离、峰值耗氧量、脑钠肽、NHYA心功能分级的变化进行分析,与室率控制治疗相比,亦有明显改善。结论导管消融与室率控制治疗持续性房颤合并心力衰竭的疗效相比,前者改善持续性房颤合并心力衰竭患者的LVEF、心功能、运动能力和生活质量的趋势更明显,但更确切的疗效有待进一步研究。 Objective To make systematic evaluation on the efficacy of catheter ablation in treating the patients with persistent atrial fibrillation(PAF) complicating heart failure(HF).Methods After systematic search in PubMed, Cochrane Library, Embase, Clinical Trials. gov, CNKI, CBM and Wanfang Database, we screened out the experiments related to comparison between the efficacy of catheter ablation and ventricular rate control in treating PAF complicating HF, and adopted them in our study. Meta analysis was performed with the software of Revman 5.3. Results We retrieved and summarized 5 randomized controlled trials, enrolling 423 patients (214 accepting the treatment of catheter ablation). Meta analysis results showed that left ventricular ejection fraction(LVEF) significantly increased after catheter ablation and MD was 5.21%(95% CI : 1.69- 8.73, P =0.004). However, obvious heterogenicity existed among different studies( I^2=80%, P =0.0006). The measurement indexes were adjusted with heterogeneous sources excluded by sensitivity analysis before being readopted into the software for Meta analysis. No heterogenicity was found among the related literatures( I^2=0%, P =0.49), and at present the MD of LVEF became 7.31%(95% CI :5.18-9.45, P <0.000 01). Simultaneously, changes of MLHFQ, 6MWT, BNP, Peak VO 2 and NHYA Class were analyzed before and after the treatment. These indexes also significantly improved if compared with those in the treatment of ventricular rate control. Conclusion Compared with the treatment of ventricular rate control, catheter ablation shows a tendency of improving LVEF, heart function, kinetism and life quality in the patients with PAF and HF, however, its specific efficacy requires for further research.
作者 尹春娥 王福军 周芳 Yin Chun-e;Wang Fu-jun;Zhou Fang(Department of No.2 Cardiology, Xiangxi Tujia Miao Autonomous Prefecture People s Hospital, the First Affiliated Hospital of Jishou University, Jishou Hunan 416000, China)
出处 《实用心电学杂志》 2019年第1期42-48,共7页 Journal of Practical Electrocardiology
关键词 导管消融 心房颤动 心力衰竭 左心室射血分数 生活质量 系统评价 catheter ablation atrial fibrillation heart failure left ventricular ejection fraction life quality systematic evaluation
  • 相关文献

参考文献4

二级参考文献45

  • 1Steinhoff JP, Sheahan RG. Tachycardia-induced cardiomyopathy: atrial fibrillation and congestive heart failure. Am J Med Sci. 200; 329:25-28. 被引量:1
  • 2Seiler J, Stevenson WG. Atrial fibrillation in congestive heart failure. Cardiol Rev 2010;18:38-50. 被引量:1
  • 3Khan MN, Jais P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008; 359:1778-1785. 被引量:1
  • 4Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351: 2373-2383. 被引量:1
  • 5Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study [J]. Circulation, 2003, 107(23): 2920-2925. 被引量:1
  • 6Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implica- tions for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study[J]. JAMA, 2001, 285(18): 2370-2375. 被引量:1
  • 7Smit MD, Moes ML, Maass AH, et al. The importance of whether atrial fibrillation or heart failure develops first [J]. Eur J Heart Fail, 2012, 14(9): 1030-1040. 被引量:1
  • 8Suzuki S, Sagara K, Otsuka T, et al. A new scoring sys- tem for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation [J]. Am J Cardiol, 2012, 110(5): 678-682. 被引量:1
  • 9Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation [J]. N Engl J Med, 2010, 362(15): 1363-1373. 被引量:1
  • 10Rienstra M, Damman K, Mulder BA, et al. Beta-blockers and outcome in heart failure and atrial fibrillation [J]. JACC Heart Fail, 2013, 1(1): 21-28. 被引量:1

共引文献55

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部